CLEVER-1
Showing 9976 - 10000 of >10,000
Advanced Solid Tumor Trial in China (PD-1 mAb injection, TJ004309 Injection)
Recruiting
- Advanced Solid Tumor
- PD-1 monoclonal antibody injection
- TJ004309 Injection
-
Hefei, Anhui, China
- +25 more
Aug 2, 2022
Placenta Accreta Trial in Cairo (packing placental site with hydrogen peroxide soaked towels, normal Saline)
Recruiting
- Placenta Accreta
- packing placental site with hydrogen peroxide soaked towels
- normal Saline
-
Cairo, EgyptKasr Alainy outpatient infertility clinic
Sep 1, 2023
International Kink Health Study
Recruiting
- Wounds and Injuries
- Mental Health
-
Rio Vista, CaliforniaTASHRA
Oct 19, 2022
Carcinoma, Squamous Cell, Non-small-cell Lung Trial in Worldwide (Pembrolizumab, Carboplatin, Paclitaxel)
Active, not recruiting
- Carcinoma, Squamous Cell, Non-small-cell Lung
- Pembrolizumab
- +5 more
-
Birmingham, Alabama
- +177 more
Aug 22, 2022
CARDio-vascular Toxicity Induced by Immune Checkpoint Inhibitors
Recruiting
- Myocarditis
- +5 more
-
Paris, FranceAP-HP, Pitié-Salpêtrière Hospital, Department of Pharmacology, C
Aug 19, 2022
NSCLC Trial (disease self-management application)
Not yet recruiting
- Non-small Cell Lung Cancer
- disease self-management application
- (no location specified)
Nov 9, 2022
Tuberculosis, Pulmonary Trial in South Africa, Tanzania (H56:IC31, Placebo)
Recruiting
- Tuberculosis, Pulmonary
- H56:IC31
- Placebo
-
Bellville, Cape Town, South Africa
- +5 more
Sep 27, 2021
The Genetic, Protein, and Lipid Basis of Variation in
Active, not recruiting
- Lipid Metabolism Disorders
-
Dallas, TexasUT Southwestern Medical Center
Dec 21, 2022
Cardiopulmonary Arrest, Pediatric ALL, Resuscitation Trial in Geneva (InterFACE (mHealth tool), Conventional methods)
Not yet recruiting
- Cardiopulmonary Arrest
- +2 more
- InterFACE (mHealth tool)
- Conventional methods
-
Geneva, SwitzerlandGeneva Children's Hospital, Geneva University Hospitals
Jan 7, 2022
Locally Advanced Esophageal Carcinoma Trial in Nanjing (Neoadjuvant Chemotherapy, Neoadjuvant Toripalimab, Short Course
Recruiting
- Locally Advanced Esophageal Carcinoma
- Neoadjuvant Chemotherapy
- +2 more
-
Nanjing, Jiangsu, ChinaJiangsu Cancer Hospital /Jiangsu Institute of Cancer Research
Jun 21, 2022
HIV-1-infection Trial in Thika (6-month PrEP + blood-based HIV self-test, 6-month PrEP + oral fluid HIV self-test)
Completed
- HIV-1-infection
- 6-month PrEP + blood-based HIV self-test
- 6-month PrEP + oral fluid HIV self-test
-
Thika, KenyaPartners in Health Research and Development - Thika House
Feb 21, 2022
Liver Transplant Failure and Rejection Trial in Madison (Ascorbic acid, Placebo)
Not yet recruiting
- Liver Transplant Failure and Rejection
- Ascorbic acid
- Placebo
-
Madison, WisconsinUniversity of Wisconsin Hospital and Clinics
Jan 11, 2023
Oropharynx Squamous Cell Carcinoma Trial (Blood sample)
Not yet recruiting
- Oropharynx Squamous Cell Carcinoma
- Blood sample
- (no location specified)
Jan 12, 2023
Depression, Anxiety Trial in Duncraig (B. adolescentis Bif-038, Lacticaseibacillus rhamnosus, LGG® and Bifidobacterium, BB-12®,
Active, not recruiting
- Depression, Anxiety
- B. adolescentis Bif-038
- +2 more
-
Duncraig, Western Australia, AustraliaClinical Research Australia
Jan 11, 2023
Diabetes, Type 2, Overweight and Obesity Trial in Chapel Hill (Behavioral weight loss with digital tools)
Completed
- Diabetes Mellitus, Type 2
- Overweight and Obesity
- Behavioral weight loss with digital tools
-
Chapel Hill, North CarolinaUniversity of North Carolina at Chapel Hill
Apr 14, 2022
Visual Acuity Trial in United States (etafilcon A with ketotifen, 1-Day ACUVUE)
Completed
- Visual Acuity
- etafilcon A with ketotifen
- 1-Day ACUVUE
-
Jacksonville, Florida
- +5 more
Mar 8, 2022
Gastric Cancer, Metastasis Trial in Shanghai (Apatinib Mesylate, Camrelizumab)
Recruiting
- Gastric Cancer
- Metastasis
- Apatinib Mesylate
- Camrelizumab
-
Shanghai, Shanghai, ChinaFudan University Shanghai Cancer Center
Oct 15, 2021
Diabetes, Type 1 Trial in United States (MYL-1501D product using manufacture process V, MYL-1501D product using manufacture
Completed
- Diabetes Mellitus, Type 1
- MYL-1501D product using manufacture process V
- MYL-1501D product using manufacture process VI
-
Fresno, California
- +37 more
Mar 1, 2022
Alcohol Drinking, Coping Skills Trial in Seattle (Drinking to Cope CBT skills)
Recruiting
- Alcohol Drinking
- Coping Skills
- Drinking to Cope CBT skills
-
Seattle, WashingtonUniversity of Washington
Apr 27, 2022
Mantle Cell Lymphoma Trial in Busan (Ixazomib)
Recruiting
- Mantle Cell Lymphoma
-
Busan, Western, Korea, Republic ofKosin University Gospel Hospital
Mar 31, 2022
Peripheral Arterial Disease, Peripheral Artery Disease Trial in Omaha (Beetroot juice)
Active, not recruiting
- Peripheral Arterial Disease
- Peripheral Artery Disease
- Beetroot juice
-
Omaha, NebraskaThe University of Nebraska at Omaha
Jun 9, 2022
Lumbar Muscle Thickness Measurements in Osteoporotic and
Not yet recruiting
- Osteoporosis
- Lomber Muscle Thickness Measurement
- (no location specified)
Apr 10, 2023
Patient Adherence, HIV Seronegativity Trial in Los Angeles, San Diego, Torrance (brief Motivational Interviewing)
Completed
- Patient Adherence
- HIV Seronegativity
- brief Motivational Interviewing
-
Los Angeles, California
- +4 more
Sep 9, 2021